The same decrease in CLL cells viability was obtained with anti-CD2 as with anti-LFA-3 (Supplementary Figure 1), confirming the role of the LFA-3/CD2 axis on the CLL cells viability. This evidence concerns the gene CD58 and B-cell chronic lymphocytic leukemia.